These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11885021)

  • 1. Treatment of malignancy by activation of the plasminogen system.
    Zacharski LR; Ornstein DL; Gabazza EC; D'Alessandro-Gabazza CN; Brugarolas A; Schneider J
    Semin Thromb Hemost; 2002 Feb; 28(1):5-18. PubMed ID: 11885021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activators: pharmacology and therapy.
    Holden RW
    Radiology; 1990 Mar; 174(3 Pt 2):993-1001. PubMed ID: 2137641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and etiopathogenetic role of plasminogen and metaloproteinase systems in the tumor growth. Pericellular proteolysis of extracellular matrix and tumor growth].
    Cosić SJ; Kovac Z
    Lijec Vjesn; 2011; 133(1-2):56-63. PubMed ID: 21644280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
    Flight SM; Masci PP; Lavin MF; Gaffney PJ
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrinolysis modulators].
    Machovich R
    Orv Hetil; 2002 Mar; 143(11):541-5. PubMed ID: 12583322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
    Sasaoka M; Wada Y; Hasumi K
    J Antibiot (Tokyo); 2007 Nov; 60(11):674-81. PubMed ID: 18057696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasminogen (fibrinolytic) system.
    Collen D
    Thromb Haemost; 1999 Aug; 82(2):259-70. PubMed ID: 10605712
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemostasis and tumor invasion. Therapeutic implications].
    Cattan A
    Bull Cancer; 1984; 71(5):481-93. PubMed ID: 6395923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasminogen activator inhibitor "paradox" in cancer.
    Binder BR; Mihaly J
    Immunol Lett; 2008 Jun; 118(2):116-24. PubMed ID: 18495253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system.
    Reijerkerk A; Mosnier LO; Kranenburg O; Bouma BN; Carmeliet P; Drixler T; Meijers JC; Voest EE; Gebbink MF
    Mol Cancer Res; 2003 Jun; 1(8):561-8. PubMed ID: 12805403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis: molecular mechanism and pathophysiological aspects.
    Lijnen HR
    Sangre (Barc); 1984; 29(4-C):755-61. PubMed ID: 6240123
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
    Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis (Review).
    Chorostowska-Wynimko J; Skrzypczak-Jankun E; Jankun J
    Int J Mol Med; 2004 Jun; 13(6):759-66. PubMed ID: 15138609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The fibrinolytic system. Endogenous and exogenous activation in the drug treatment of thrombosis].
    Meneghini P; Giuron G; Gallo L; Lo Pinto G; Claudiani F
    Recenti Prog Med; 1982 Jun; 72(6):770-800. PubMed ID: 6216564
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
    López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
    Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin/plasminogen system in colorectal cancer.
    Berger DH
    World J Surg; 2002 Jul; 26(7):767-71. PubMed ID: 11965442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.